[Quality assured HER2 analysis in breast cancer. Important therapeutic predictive and prognostic factor]

Lakartidningen. 2008 Aug;105(32-33):2181-4.
[Article in Swedish]
No abstract available

MeSH terms

  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents / therapeutic use
  • Biomarkers, Tumor / analysis*
  • Breast Neoplasms / diagnosis*
  • Breast Neoplasms / drug therapy
  • Breast Neoplasms / metabolism
  • Breast Neoplasms / pathology
  • Disease Progression
  • Female
  • Humans
  • Immunohistochemistry / standards
  • In Situ Hybridization, Fluorescence / standards
  • Predictive Value of Tests
  • Prognosis
  • Quality Assurance, Health Care
  • Receptor, ErbB-2 / analysis*
  • Receptor, ErbB-2 / metabolism
  • Reproducibility of Results
  • Risk Assessment
  • Surveys and Questionnaires
  • Trastuzumab

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • Biomarkers, Tumor
  • Receptor, ErbB-2
  • Trastuzumab